InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: Whalatane post# 378811

Sunday, 05/29/2022 4:38:49 PM

Sunday, May 29, 2022 4:38:49 PM

Post# of 426487
"Statins are only used by roughly 50% of secondary prevention patients I believe …. And they have been around since 1987"


Statins have a higher rate of site effects than Vascepa with its near placebo like profile...I would be happy with Vascepa being used for just 5% of secondary prevention patients...This is attainable in much less time...particularly with the advent of combo statin-Vascepa drugs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News